Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City.
about
Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge.Age and sex or gender (sex/gender) and HIV vaccine preparedness.Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical preventionEnhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.Using social networks to recruit an HIV vaccine preparedness cohortHIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries.HIV vaccine trial preparedness among Spanish-speaking Latinos in the US.In "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine StudyPromoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?Venue-based recruitment of women at elevated risk for HIV: an HIV Prevention Trials Network study.An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.Addressing research priorities for prevention of HIV infection in the United StatesReasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, TanzaniaThe potential role of biomarkers in HIV preventive vaccine trialsTime will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuationLessons drawn from recent HIV vaccine efficacy trials.Recruitment of HIV-Positive Women in Research: Discussing Barriers, Facilitators, and Research Personnel's KnowledgeSocioecological influences on community involvement in HIV vaccine researchChallenges in the design of HIV prevention trials in the United States.Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trialsUnderstanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial.Retention strategies and factors associated with missed visits among low income women at increased risk of HIV acquisition in the US (HPTN 064).Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial.The effect of peer-driven intervention on rates of screening for AIDS clinical trials among African Americans and Hispanics.Retaining hard-to-reach women in HIV prevention and vaccine trials: Project ACHIEVECost-effectiveness analysis of recruitment strategies in a community-based intervention study of HIV-infected persons
P2860
Q25255907-4F8DB4C3-34A0-4B83-9A7B-E6AF64B5A4DAQ30202232-D8D3C516-E94E-4175-81A4-8203B6CC1A8FQ30206105-E082C54B-FC27-42AA-9B94-FDBD3E95A931Q30223510-D6A8BB44-D5FD-4204-AB6E-F427D294BB07Q30227795-F515044C-D097-4CF2-971B-74458474FDDCQ30229401-5273B154-6B76-46F4-89F6-EEB35559F2B3Q30230248-8F6CEF52-6697-4274-8EE2-DF49939CD420Q30378981-F5E32442-2A37-4EAC-AB8E-8DE691370CCBQ30392323-63D13254-E7C5-4B2E-8314-42BDC872796AQ33714437-1BE2831D-4567-47D9-A4F0-7F819700F11CQ33807022-FBBA560B-8989-41AE-A153-686D58A2DEB5Q33822456-DFAEDC63-BDB9-4FB2-B157-7E5FA2B0E5CEQ33831829-5968A58D-A025-4A70-9B1B-50CBE50EDE30Q34059957-7D1D0DEE-955D-4911-A5AE-BF2EDB3FEA91Q34376994-F8CE2A2E-04EA-43B9-8A03-41C0026E4020Q34816639-D6CF0C08-AF06-4A39-9C4A-CCCEB14F79DAQ34997670-3B7CAE20-0E59-483C-A570-EBB4699A2F36Q35207849-43890E84-0E2E-4632-AAC6-BCDA1EC7F496Q35819672-E5C63427-16D0-4B97-B89F-26FE8774AF10Q36790642-2F435DFB-44CC-4DCF-9B0B-A86812728C9BQ36853358-E44EA647-D6ED-43A0-B1EE-DA5150395819Q37701086-9426F040-37AC-41FC-9B03-5F344A145E3FQ40299980-ADFAE27F-D2AA-4610-ACF4-22CA088F3E85Q55446924-F9C32E75-83C4-4090-9CED-A251582F282AQ57117710-0CD87305-5610-40B3-B793-3500B94A54C4Q58306670-A1760345-74E6-4760-9D52-2057966E9208
P2860
Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Involving women in HIV vaccine ...... edness study in New York City.
@ast
Involving women in HIV vaccine ...... edness study in New York City.
@en
type
label
Involving women in HIV vaccine ...... edness study in New York City.
@ast
Involving women in HIV vaccine ...... edness study in New York City.
@en
prefLabel
Involving women in HIV vaccine ...... edness study in New York City.
@ast
Involving women in HIV vaccine ...... edness study in New York City.
@en
P2093
P2860
P356
P1476
Involving women in HIV vaccine ...... edness study in New York City.
@en
P2093
B A Koblin
M A Chiasson
P Brown-Peterside
P2860
P2888
P304
P356
10.1007/BF02386751
P577
2000-09-01T00:00:00Z